Argus•March 27, 2024

EW: Lowering target price to $98.00

Symbols

Sector(s)

Healthcare

Rating

Current Price

$86.43

Price Target

Earnings Estimate

Summary

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment

Upgrade to begin using premium research reports and get so much more.

Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level